▲ Respiratory Infections

HWTS-RT201A/B/C/D-RSV/ADV Ag Rapid Test

The kit is intended for in vitro qualitatively detecting antigens of Respiratory Syncytial Virus and Adenovirus in samples of nasal swabs from suspects of infection within 7 days of symptom on-set and close contacts in differential diagnosis of respiratory tract infection by Respiratory Syncytial Virus and Adenovirus. The test results should not be used as the sole basis for clinical decision of diagnosis and treatment. Further clinical diagnosis should be confirmed with alternative testing method(s) in combination with other clinical findings.

The kit was in vitro diagnostics only and it is not automated.
HWTS-RT065A/B/C/D-COVID-19 /Flu A &B/ RSV/ADV Ag Combo Rapid Test

The kit is intended for in vitro qualitatively detecting antigens of SARS-CoV-2, Influenza virus A and B, Respiratory Syncytial Virus, and Adenovirus in samples of nasal swabs from suspects of infection within 7 days of symptom onset and close contacts in differential diagnosis of respiratory tract infection by SARS-CoV-2, Influenza Virus A and B, Respiratory Syncytial Virus, and Adenovirus. The test results should not be used as the sole basis for clinical decision of diagnosis and treatment. Further clinical diagnosis should be confirmed with alternative testing method(s) in combination with other clinical findings. The kit is for in vitro diagnostic use only and is not automated.
HWTS-RT200A/B/C/D-COVID-19/ Flu A&B Ag Rapid Test

The kit is intended for in vitro qualitatively detecting antigens of SARS-CoV-2, Influenza virus A and B in samples of nasal swabs from suspects of infection within 7 days of symptom onset and close contacts in differential diagnosis of respiratory tract infection by SARS-CoV-2, Influenza Virus A and B. The test results should not be used as the sole basis for clinical decision of diagnosis and treatment. Further clinical diagnosis should be confirmed with alternative testing method(s) in combination with other clinical findings. The kit is for in vitro diagnostics only and is not automated.
Human Metapneumovirus Antigen

This kit is used for qualitative detection of human metapneumovirus antigens in oropharyngeal swab, nasal swabs, and nasopharyngeal swab samples.
SARS-CoV-2,Influenza A&B Antigen, Respiratory Syncytium, Adenovirus and Mycoplasma Pneumoniae combined

This kit is used for qualitative detection of SARS-CoV-2, influenza A&B antigen, Respiratory Syncytium, adenovirus and mycoplasma pneumoniae in nasopharyngeal swab、oropharyngeal swaband nasal swab samples in vitro, and can be used for differential diagnosis of novel coronavirus infection, respiratory syncytial virus infection, adenovirus, mycoplasma pneumoniae and influenza A or B virus infection. The test results are only for clinical reference, and cannot be used as the only basis for diagnosis and treatment.
SARS-CoV-2, Respiratory Syncytium, and Influenza A&B Antigen Combined

This kit is used for the qualitative detection of SARS-CoV-2, respiratory syncytial virus and influenza A&B antigens in vitro, and can be used for the differential diagnosis of SARS-CoV-2 infection, respiratory syncytial virus infection, and influenza A or B virus infection[1]. The test results are for clinical reference only and cannot be used as the sole basis for diagnosis and treatment.
Influenza A Virus H5N1 Nucleic Acid Detection Kit

This kit is suitable for the qualitative detection of influenza A virus H5N1 nucleic acid in human nasopharyngeal swab samples in vitro.
Influenza A/B Antigen

This kit is used for the qualitative detection of influenza A and B antigens in oropharyngeal swab and nasopharyngeal swab samples.
Adenovirus Antigen

This kit is intended for in vitro qualitative detection of Adenovirus(Adv) antigen in oropharyngeal swabs and nasopharyngeal swabs.
Respiratory Syncytial Virus Antigen

This kit is used for the qualitative detection of respiratory syncytial virus (RSV) fusion protein antigens in nasopharyngeal or oropharyngeal swab specimens from neonates or children under 5 years of age.